(Q53423870)

14 May 2018

title

Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients. (English)

1 reference

14 May 2018

1 reference

invasive aspergillosis

1 reference

1

1 reference

14 May 2018

author name string

Su-Mi Choi

2

1 reference

14 May 2018

Dong-Gun Lee

3

1 reference

14 May 2018

Jung-Hyun Choi

4

1 reference

14 May 2018

Si-Hyun Kim

5

1 reference

14 May 2018

Jae-Cheol Kwon

6

1 reference

14 May 2018

Jin-Hong Yoo

7

1 reference

14 May 2018

Hee-Je Kim

8

1 reference

14 May 2018

Seok Lee

9

1 reference

14 May 2018

Ki-Seong Eom

10

1 reference

14 May 2018

Woo-Sung Min

11

1 reference

14 May 2018

publication date

23 May 2011

1 reference

14 May 2018

published in

Mycoses

1 reference

14 May 2018

volume

54

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

page(s)

523-530

1 reference

14 May 2018

Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Fungal infections in leukemia patients: how do we prevent and treat them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Laboratory diagnosis of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Changes in causes of death over time after treatment for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Kappa coefficients in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

False-positive Aspergillus galactomannan antigen test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2010.02009.X

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1111/J.1439-0507.2010.02009.X

1 reference

14 May 2018

PubMed ID

21605195

1 reference

14 May 2018